Ignite Creation Date:
2025-12-24 @ 2:30 PM
Ignite Modification Date:
2026-02-22 @ 4:52 PM
Study NCT ID:
NCT04377659
Status:
TERMINATED
Last Update Posted:
2025-05-28
First Post:
2020-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-04
First Submit QC Date:
None
Study First Post Date:
2020-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-09
Results First Submit QC Date:
None
Results First Post Date:
2023-06-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-13
Last Update Post Date:
2025-05-28
Last Update Post Date Type:
ACTUAL